BEAM - Beam Therapeutics to cut 20% of workforce; sees cash runway into 2026
2023-10-19 09:56:55 ET
More on Beam Therapeutics
- Beam Therapeutics: Rich In Cash, Poor In Punctuality (Rating Downgrade)
- Beam Therapeutics: Awaiting Clinical Progress And Path Towards Profitability
- Seeking Alpha’s Quant Rating on Beam Therapeutics
- Historical earnings data for Beam Therapeutics
- Financial information for Beam Therapeutics
For further details see:
Beam Therapeutics to cut 20% of workforce; sees cash runway into 2026